CLINICAL_TRIALS
research
· 2026-01-26
Clinical Trial Update: Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma [Phase 2]
Summary
A Phase 2 clinical trial update for Irinotecan-ChemoSeed in surgically resectable glioblastoma; the study is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CRISM Therapeutics LTD | Conditions: Glioblastoma | Phase 2 | Status: NOT_YET_RECRUITING